...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Study on Synthesis and Biological Evaluation of 3-Aryl Substituted Xanthone Derivatives as Novel and Potent Tyrosinase Inhibitors
【24h】

Study on Synthesis and Biological Evaluation of 3-Aryl Substituted Xanthone Derivatives as Novel and Potent Tyrosinase Inhibitors

机译:3-芳基取代的X原蝶酮衍生物作为新型和有效酪氨酸酶抑制剂的合成与生物学评价研究

获取原文
           

摘要

Tyrosinase plays a key role in the melanin biosynthesis since it catalyzes the transformation of tyrosine into L-dopaquinone. A large number of studies have also shown that molecules to efficiently inhibit the activity of tyrosinase would be potentially used in treating many depigmentation-related disorders. In this study, we targeted a series of structure-based 3-aryl substituted xanthone derivatives in which diverse functional groups were respectively attached on 3-aromatic ring moiety as new tyrosinase inhibitors. The results demonstrated that all obtained compounds had potent tyrosinase inhibitory activities with ICsub50/sub values at micromolar range. Especially, compound 4t was found to be the most active tyrosinase inhibitor with the ICsub50/sub value of 11.3?μM, uncovering that the introduction of the proper hydroxyl group in the 3-aromatic ring was beneficial for enhancing the inhibitory potency against tyrosinase. Moreover, the inhibition mechanism and inhibition kinetics studies revealed that compound 4t presented such inhibitory effect by acting as the reversible and competitive–uncompetitive mixed-II type inhibitor. Further molecular docking simulation showed that 3-aromatic ring of compound 4t was inserted into the narrow regions of binuclear copper-binding site at the bottom of the enzyme binding pocket, while the xanthone skeleton was positioned at the surface of tyrosinase. Taken together, these data suggested that such type of molecules might be utilized for the development of new and promising candidate for the treatment of depigmentation-related disorders.
机译:酪氨酸酶在黑色素生物合成中起着关键作用,因为它催化酪氨酸转化为L-多醌的转化。大量研究还表明,有效地抑制酪氨酸酶活性的分子可能用于治疗许多与抗衰减相关疾病。在这项研究中,我们靶向了一系列基于结构的3-芳基取代的X原酮衍生物,其中各种官能团分别在3-芳环部分上作为新的酪氨酸酶抑制剂。结果表明,所有得到的化合物都有有效的酪氨酸酶抑制活性,Micromolar范围内具有IC 50 值。特别是,发现化合物4T是最活性的酪氨酸酶抑制剂,其IC 50 值为11.3Ωμm,揭示了3-芳环中的适当羟基的引入有利于增强抑制酪氨酸酶的抑制效力。此外,抑制机制和抑制动力学研究表明,化合物4T通过用作可逆和竞争的小竞争性混合-II型抑制剂来呈现这种抑制作用。进一步的分子对接模拟表明,将化合物4T的3-芳香环插入酶结合口袋底部的双核铜结合位点的窄区域中,而X原酮骨架位于酪氨酸酶的表面。总之,这些数据表明,这种类型的分子可用于开发新的和有前途的候选者,用于治疗分析相关疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号